ArticleAmerican journal of hematology2022

Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.

Meera Mohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.